Idelalisib

{{DrugProjectFormSinglePage |authorTag=Alberto Plate [1] |genericName=Idelalisib |aOrAn=an |drugClass=antineoplastic agent |indicationType=treatment |indication=relapsed chronic lymphocytic leukemia, relapsed [[follicular b-cell non-hodgkin lymphoma and relapsed small lymphocytic lymphoma |blackBoxWarningTitle=TITLE |blackBoxWarningBody=Condition Name: (Content) |offLabelAdultGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Idelalisib in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Idelalisib in adult patients. |offLabelPedGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Idelalisib in pediatric patients. |offLabelPedNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Idelalisib in pediatric patients. |alcohol=Alcohol-Idelalisib interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication. }}